A phase II study of thalidomide (Thalomid), clarithromycin (Biaxin), lenalidomide(Revlimid), and dexamethasone (Decadron) for subjects with newly diagnosed multiple myeloma
Phase of Trial: Phase II
Latest Information Update: 28 Jun 2017
At a glance
- Drugs Thalidomide (Primary) ; Clarithromycin; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms T-BiRD
- 13 Dec 2007 Status changed from initiated to recruiting.
- 09 Oct 2007 New trial record.